Vitamin B12 supplements may help treat hepatitis C
Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body's ability to keep the virus at bay, indicates a pilot study published online in the journal Gut.
Diseases, Conditions, Syndromes
Jul 17, 2012 |
not rated yet |
0
Timing, duration of biochemical bugle call critical for fighting viruses
Researchers have identified the primary player of the biochemical bugle call that musters the body's defenders against viral infection.
Medical research
Jun 13, 2012 |
not rated yet |
0
|
Hepatitis C drug can cause depression
There's a high rate of depression among patients with hepatitis C, but a standard treatment for the disease includes a drug, interferon, that can cause depression.
Medications
May 01, 2012 |
not rated yet |
0
|
Omega-3 fatty acids not associated with beneficial effects in multiple sclerosis: study
Omega-3 fatty acid supplements were not associated with beneficial effects on disease activity in patients with relapsing-remitting multiple sclerosis, according to a report of a randomized controlled trial published Online ...
Neuroscience
Apr 23, 2012 |
1 / 5 (1) |
0
|
Positive results trial for new asthma treatment
Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, into the effectiveness of the ...
Diseases, Conditions, Syndromes
Apr 19, 2012 |
4 / 5 (1) |
0
Drug interactions won't exclude HCV transplant or HIV co-infected patients from treatment
New data from a number of clinical trials presented for the first time at the International Liver Congress 2012 provides hope for previously difficult to treat hepatitis C (HCV) patient populations.
Diseases, Conditions, Syndromes
Apr 19, 2012 |
not rated yet |
0
Study reveals trigger that may speed melanoma growth
(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.
Cancer
Mar 28, 2012 |
5 / 5 (3) |
0
|
How music prevents heart transplant rejection
Music has a fundamental affect on humans. It can reduce stress, enhance relaxation, provide a distraction from pain, and improve the results of clinical therapy. New research published in BioMed Central's open access journal ...
Cardiology
Mar 22, 2012 |
5 / 5 (2) |
1
|
Hypoferremia predicts treatment response to IFN-α
(HealthDay) -- For patients with hepatitis C virus (HCV), hepcidin, a regulator of iron homeostasis, is induced following a single dose of pegylated interferon-α (PEG-IFNα), and may be a surrogate marker of immediate ...
Diseases, Conditions, Syndromes
Mar 01, 2012 |
not rated yet |
0
Study of patients infected with both HIV and hepatitis shows how the drug interferon works to suppress virus
A drug once taken by people with HIV/AIDS but long ago shelved after newer, modern antiretroviral therapies became available has now shed light on how the human body uses its natural immunity to fight the virus—work ...
Medications
Feb 29, 2012 |
5 / 5 (1) |
0
|
Targeted drug helps leukemia patients who do not benefit from initial therapy
A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib. Published early online ...
Cancer
Feb 27, 2012 |
5 / 5 (1) |
0
Hepatitis C kills more Americans than HIV: study
More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS, US health authorities said this week.
Diseases, Conditions, Syndromes
Feb 23, 2012 |
4.5 / 5 (2) |
0
Genetic diversity: Crucial for our survival in many ways
(Medical Xpress) -- Thanks to the sequencing of the 27 known human interferon genes, researchers from the Institut Pasteur and the CNRS reconstruct the genetic history of these proteins so central for our immune system, and ...
Genetics
Dec 20, 2011 |
4 / 5 (1) |
0
Boceprevir: Indication of added benefit for specific patients
The active ingredient boceprevir has been available since the middle of 2011 as a treatment for chronic hepatitis C of genotype 1. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal ...
Diseases, Conditions, Syndromes
Dec 09, 2011 |
5 / 5 (1) |
0
Discordance among commercially-available diagnostics for latent TB infection
In populations with a low prevalence of tuberculosis (TB), the majority of positives with the three tests commercially available in the U.S for the diagnosis of TB are false positives, according to a new study.
Diseases, Conditions, Syndromes
Dec 09, 2011 |
not rated yet |
0
